Related Experiment Videos
[Thrombocytopathia with cyclo-oxygenase deficiency]
Nouvelle Revue Francaise D'Hematologie
|January 1, 1976
Summary
This study identifies cyclo-oxygenase deficiency in four patients, impacting platelet aggregation and serotonin release. These findings are crucial for understanding bleeding disorders.
Area of Science:
- Hematology
- Biochemistry
- Molecular Biology
Context:
- Platelet aggregation is vital for hemostasis.
- Cyclo-oxygenase (COX) pathway is critical for thromboxane A2 synthesis.
- Defects in platelet function can lead to bleeding disorders.
Purpose:
- To investigate platelet aggregation and function in patients with suspected hemostasis defects.
- To identify the underlying molecular cause of impaired platelet activity.
Summary:
- Four patients exhibited absent platelet aggregation with arachidonate but normal responses to Labile Aggregation Stimulating Substance.
- Adenosine diphosphate (ADP) induced aggregation was reversible; collagen-induced aggregation was absent, while thrombin and ristocetin responses were normal.
- These platelets showed no thromboxane B2 synthesis, with impaired 14C-serotonin release upon collagen stimulation but some release with thrombin.
- Two patients had hereditary hemostasis defects, and the others presented with acquired cyclo-oxygenase deficiency.
Impact:
- Elucidates the role of cyclo-oxygenase in platelet function and hemostasis.
- Provides insights into the pathophysiology of bleeding disorders caused by COX deficiency.
- Contributes to the diagnostic understanding of platelet dysfunction syndromes.